The IGF-I Axis in Thyroid Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|7|729-735

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.7, 2007-03, pp. : 729-735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The IGF-I Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 663-669

Bentham Science Publishers

Access to resources Recommend Favorite

IGF-I Abuse in Sport

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 3, 2009-09 ,pp. : 263-272

Bentham Science Publishers

Access to resources Recommend Favorite

The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer

By  

Current Medicinal Chemistry, Vol. 12, Iss. 24, 2005-11 ,pp. : 2881-2891

Bentham Science Publishers

Access to resources Recommend Favorite

Depot somatropin: gender affects IGF-I response

By  

Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Pharmacological Characteristics of Parenteral IGF-I Administration

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 2, 2003-04 ,pp. : 123-140

Bentham Science Publishers

Access to resources Recommend Favorite